Head of Clinical Evidence Strategy

Siemens Healthineers

About The Position

Join us in pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our inspiring and caring environment forms a global community that celebrates diversity and individuality. We encourage you to step beyond your comfort zone, offering resources and flexibility to foster your professional and personal growth, all while valuing your unique contributions. The Head of Clinical Evidence Strategy is the most senior leader responsible for evidence generation across the Diagnostics business. This role serves as the central strategic authority for clinical evidence supporting clinical innovation (e.g., RUO), product development, and lifecycle value demonstration. The position oversees global integrated evidence generation teams and leads the design and execution of evidence strategies spanning non-registrational research, registrational studies, and Health Economics and Outcomes Research (HEOR). This leader drives global, portfolio-level evidence planning across diverse markets to generate guideline-ready and payer-ready evidence that supports product development, launch, adoption, and long-term value. The role operates both internally and externally providing functional leadership, engaging customers and thought leaders, and advancing scientific exchange to demonstrate the clinical and economic value of diagnostics solutions.

Requirements

PhD (clinical focus) or MD in a relevant clinical or scientific discipline.
Strong business acumen with exceptional communication and interpersonal skills.
Proven ability to influence and engage stakeholders at all organizational levels.
Extensive Medical Affairs experience with leadership of integrated evidence planning and generation teams.
Demonstrated ability to build high-performing teams and drive cross-functional alignment and shared ownership.
Systems-oriented leadership approach with a track record of building scalable, durable capabilities.
Deep understanding of medical governance, regulatory requirements, and compliance frameworks.
Minimum of 10 years of senior leadership experience in the life sciences industry, preferably in medical technology and/or in vitro diagnostics (IVD).
Fluency in English.

Responsibilities

Lead the development of global evidence generation strategies and integrated evidence plans aligned with priority clinical innovation areas and the strategic direction of global and regional Diagnostics leadership.
Design and oversee a broad range of evidence initiatives, including interventional and non-interventional studies for both non-registrational and registrational purposes (including submissions to competent authorities such as the U.S. Food and Drug Administration), HEOR studies, and real-world evidence programs.
Drive clinical and scientific excellence by fostering partnerships with leading experts and institutions, enabling evidence generation that supports successful product launch, adoption, and differentiation.
Ensure full compliance with all applicable regulatory requirements and internal regional and global SOPs across all evidence generation activities.
Initiate and, when appropriate, lead external scientific collaborations with medical institutions, professional societies, and other stakeholders to advance strategic evidence initiatives.
Conduct ongoing gap assessments to identify unmet scientific and strategic evidence needs, aligning global and regional priorities and ensuring coordinated execution.
Establish clear strategic prioritization and operational discipline, particularly within accelerated innovation and product development timelines.
Advance the adoption of innovative evidence methodologies—including AI/ML, advanced analytics, and large-scale data analysis—to generate meaningful insights and strengthen evidence impact.
Represent the function in cross-functional leadership forums (internal and external), define performance metrics for evidence programs, and communicate progress and impact to executive leadership.
Build and scale cross-functional operating models that institutionalize integrated evidence planning, ensuring sustained strategic alignment and execution beyond individual teams or initiatives.